Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SONAFUSION Registry (Long-term Evaluation of Sonablate High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer and Benign Prostatic Hyperplasia)

NCT07757490 is registered in ClinicalTrials.gov with Sonablate as lead sponsor.

NCT NCT07757490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07757490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SONAFUSION Registry (Long-term Evaluation of Sonablate High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer and Benign Prostatic Hyperplasia)
Lead sponsor
Sonablate
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2015
Completion date
December 31, 2035
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bph (benign prostatic hyperplasia), localized prostate cancer, prostate cancer; benign prostatic hyperplasia